Biological role and regulation of circular RNA as an emerging biomarker and potential therapeutic target for cancer
Molecular Biology Reports · 2024
DOI: 10.1007/s11033-024-09211-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2024. Verfasst von Ayman Saleem und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. Hauptthemen laut MEDLINE: MicroRNAs, Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 139 Literaturangaben.
Abstract (Originalsprache)
Circular RNAs (circRNAs) are a unique family of endogenous RNAs devoid of 3' poly-A tails and 5' end caps. These single-stranded circRNAs, found in the cytoplasm, are synthesized via back-splicing mechanisms, merging introns, exons, or both, resulting in covalently closed circular loops. They are profusely expressed across the eukaryotic transcriptome and offer heightened stability against exonuclease RNase R compared to linear RNA counterparts. This review endeavors to provide a comprehensive overview of circRNAs' characteristics, biogenesis, and mechanisms of action. Furthermore, aimed to shed light on the potential of circRNAs as significant biomarkers in various cancer types. It has been performed an exhaustive literature review, drawing on recent studies and findings related to circRNA characteristics, synthesis, function, evaluation techniques, and their associations with oncogenesis. CircRNAs are intricately associated with tumor progression and development. Their multifaceted roles encompass gene regulation through the sponging of proteins and microRNAs, controlling transcription and splicing, interacting with RNA binding proteins (RBPs), and facilitating gene translation. Due to these varied roles, circRNAs have become a focal point in tumor pathology investigations, given their promising potential as both biomarkers and therapeutic agents. CircRNAs, due to their unique biogenesis and multifunctionality, hold immense promise in the realm of oncology. Their stability, widespread expression, and intricate involvement in gene regulation underscore their prospective utility as reliable biomarkers and therapeutic targets in cancer. As our understanding of circRNAs deepens, advanced techniques for their detection, evaluation, and manipulation will likely emerge. These advancements might catalyze the translation of circRNA-based diagnostics and therapeutics into clinical practice, potentially revolutionizing cancer care and prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
- Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan. muhammad.umer4@mlt.uol.edu.pk.
- Centre for Applied Molecular Biology, University of the Punjab, Lahore, Pakistan.
- Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. daniela.calina@umfcv.ro.
- Facultad de Medicina, Universidad del Azuay, Cuenca, Ecuador. javad@uazuay.edu.ec.
Zitieren
APA
Saleem, A., Khan, M. U., Zahid, T., Khurram, I., Ghani, M. U., Ullah, I., Munir, R., Calina, D., & Sharifi-Rad, J. (2024). Biological role and regulation of circular RNA as an emerging biomarker and potential therapeutic target for cancer. Molecular Biology Reports. https://doi.org/10.1007/s11033-024-09211-3
Vancouver
Saleem A, Khan MU, Zahid T, Khurram I, Ghani MU, Ullah I, et al. Biological role and regulation of circular RNA as an emerging biomarker and potential therapeutic target for cancer. Molecular Biology Reports. 2024. doi:10.1007/s11033-024-09211-3
BibTeX
@article{Saleem2024,
author = {Saleem, Ayman and Khan, Muhammad Umer and Zahid, Tazeen and Khurram, Iqra and Ghani, Muhammad Usman and Ullah, Inam and Munir, Rakhtasha and Calina, Daniela and Sharifi-Rad, Javad},
title = {Biological role and regulation of circular RNA as an emerging biomarker and potential therapeutic target for cancer},
journal = {Molecular Biology Reports},
year = {2024},
doi = {10.1007/s11033-024-09211-3}
}
EUVIMED